Please assess the completion status of the following clinical trial:

Trial Title: Antifungal Prophylaxis in Intensive Care Unit (ICU) Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* surgical patients admitted to our ICU older than 18 years of age and expected to require invasive mechanical ventilation for more than 48 h.~Exclusion Criteria:~* pregnancy,~* proven Candida infection,~* prophylactic or curative antifungal treatment within the last 2 months,~* contraindication to oral drug administration,~* known allergy to nystatin or its derivatives, and prior inclusion in the study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Nystatin (Type: ACTIVE_COMPARATOR): surgical patients admitted to our ICU older than 18 years of age and expected to require invasive mechanical ventilation for more than 48 h.Patients were allocated to receive systematic nystatin prophylaxis (2 x 106 U per day administered three times daily in the naso-gastric tube)
- Control (Type: PLACEBO_COMPARATOR): surgical patients admitted to our ICU older than 18 years of age and expected to require invasive mechanical ventilation for more than 48 h.

Based on this trial design, predict the completion outcome and termination type (if applicable).